Description
List of contributors. Preface. Introduction. Platinum anticancer drugs. Gold. Ruthenium compounds in cancer therapy. Rhodium, iridium and palladium compounds as experimental anticancer drugs. Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes – early transition metal antitumour drugs. Antitumour activity of tin compounds. Gallium compounds in cancer therapy. Bleomycin and metal interactions. The in vivo use of metallic radioisotopes in cancer detection and imaging. Index.
